Litcius/Paper detail

Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab

Filippo Gustavo Dall’Olio, Diletta Calabrò, Nicole Conci, Giulia Argalia, Paola Valeria Marchese, Francesca Fabbri, Benedetta Fragomeno, Dalia Ricci, Stefano Fanti, Valentina Ambrosini, Andrea Ardizzoni

2021European Journal of Cancer52 citationsDOI

Topics & Concepts

Positron emission tomographyMedicineLung cancerNuclear medicineComputed tomographyBiomarkerPositron Emission Tomography-Computed TomographyTomographyCancerRadiologyOncologyInternal medicineChemistryBiochemistryMedical Imaging Techniques and ApplicationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab | Litcius